CompletedNot applicableNCT00843635

Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx

Studying Squamous cell carcinoma of oral cavity and lip

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Donald T. Weed
Principal Investigator
Donald T. Weed, MD, MD
University of Miami Sylvester Comprehensive Cancer Center
Intervention
Tadalafil(drug)
Enrollment
35 enrolled
Eligibility
18-120 years · All sexes
Timeline
20082015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00843635 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

See all trials for Squamous cell carcinoma of oral cavity and lip

← Back to all trials